The global Glycomics/Glycobiology Market was valued at USD 649.23 million in 2016 and is projected to reach USD 1,986.33 million by 2025, growing at a CAGR of 13.23% from 2017 to 2025.
Glycobiology is the study of the structure, biosynthesis, and biology of saccharides (sugar chains or glycans). The market is expected to grow at a high CAGR in near future due to expansion of biotechnology and proteomics in R&D and pharmaceutical sector.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure
1.2 Growth of the Proteomics Market
1.3 Technological Advancements in Glycomics Instrumentation
1.4 Growing Focus of Market Players on Glycomics/Glycobiology
2. Market Restraints
2.1 Stringent Regulatory Frameworks
2.2 High Degree of Consolidation
Market Segmentation:
1. Global Glycomics/GlycobiologyMarket, by Application:
1.1 Diagnostics
1.2 Drug Discovery & Development
1.3 Oncology
1.4 Immunology
1.5 Other Applications
2. Global Glycomics/GlycobiologyMarket, by End User:
2.1 Academic Research Institutes
2.2 Pharmaceutical & Biotechnology Companies
2.3 Contract Research Organizations
3. Global Glycomics/Glycobiology Market, by Product:
3.1 Kits
3.1.1 Glycan Labeling Kits
3.1.2 Glycan Purification Kits
3.1.3 Glycan Release Kits
3.1.4 Other Glycomics Kits
3.2 Enzymes
3.2.1 Glycosidases
3.2.2 Glycosyltransferases
3.2.3 Neuraminidases
3.2.4 Sialyltransferases
3.2.5 Other Glycomics Enzymes
3.3 Instruments
3.3.1 Antibody Arrays
3.3.2 HPLC
3.3.3 Lectin Arrays
3.3.4 MALDI-TOF
3.3.5 Mass Spectrometers
3.3.6 Other Glycomics Instruments
3.4 Reagents
3.4.1 Glycoproteins
3.4.2 Monosaccharides
3.4.3 Oligosaccharides
3.4.4 Other Reagents
4. Global Glycomics/Glycobiology Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Merck KGaA
2. Takara Bio, Inc.
3. Shimadzu Corporation
4. Bruker Corporation
5. Waters Corporation
6. New England Biolabs Inc.
7. Agilent Technologies, Inc.
8. Danaher Corporation
9. ProZyme, Inc.
10. Thermo Fisher Scientific, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Glycomics/GlycobiologyMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL GLYCOMICS/GLYCOBIOLOGYMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL GLYCOMICS/GLYCOBIOLOGYMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET, BY APPLICATION
5.1 Diagnostics
5.2 Drug Discovery & Development
5.3 Oncology
5.4 Immunology
5.5 Other Applications
6 GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET, BY END USER
6.1 Academic Research Institutes
6.2 Pharmaceutical & Biotechnology Companies
6.3 Contract Research Organizations
7 GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET, BY PRODUCT
7.1 Kits
7.1.1 Glycan Labeling Kits
7.1.2 Glycan Purification Kits
7.1.3 Glycan Release Kits
7.1.4 Other Glycomics Kits
7.2 Enzymes
7.2.1 Glycosidases
7.2.2 Glycosyltransferases
7.2.3 Neuraminidases
7.2.4 Sialyltransferases
7.2.5 Other Glycomics Enzymes
7.3 Instruments
7.3.1 Antibody Arrays
7.3.2 HPLC
7.3.3 Lectin Arrays
7.3.4 MALDI-TOF
7.3.5 Mass Spectrometers
7.3.6 Other Glycomics Instruments
7.4 Reagents
7.4.1 Glycoproteins
7.4.2 Monosaccharides
7.4.3 Oligosaccharides
7.4.4 Other Reagents
8 GLOBAL GLYCOMICS/GLYCOBIOLOGYMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL GLYCOMICS/GLYCOBIOLOGYMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Merck KGaA
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Takara Bio, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Shimadzu Corporation
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Bruker Corporation
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Waters Corporation
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 New England Biolabs Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Agilent Technologies, Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Danaher Corporation
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 ProZyme, Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Thermo Fisher Scientific, Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Reports